Headinvest, LLC Oncolytics Biotech Inc Transaction History
Headinvest, LLC
- $472 Million
- Q3 2025
A detailed history of Headinvest, LLC transactions in Oncolytics Biotech Inc stock. As of the latest transaction made, Headinvest, LLC holds 44,700 shares of ONCY stock, worth $46,935. This represents 0.01% of its overall portfolio holdings.
Number of Shares
44,700
Previous 44,834
0.3%
Holding current value
$46,935
Previous $34,000
82.35%
% of portfolio
0.01%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding ONCY
# of Institutions
58Shares Held
2.82MCall Options Held
0Put Options Held
0-
Morgan Stanley New York, NY383KShares$402,5130.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il382KShares$401,1530.0% of portfolio
-
Marshall Wace, LLP London, X0324KShares$340,1810.0% of portfolio
-
Seeds Investor LLC New York, NY258KShares$271,2210.08% of portfolio
-
Goldman Sachs Group Inc New York, NY209KShares$219,1320.0% of portfolio
About ONCOLYTICS BIOTECH INC
- Ticker ONCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 57,867,400
- Market Cap $60.8M
- Description
- Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of solid tumors and hematological malignancies. Oncolytics Biotech Inc. has a...